GSK3B and cancer: Subsequently, IL1-β secreted by TAMs stabilizes intracellular β-catenin potentiating Wnt signaling in cancer cells via NFkB/PDK1 [23] and glycogen synthase kinase 3-beta (GSK3β) inhibition, whereas IL-6 further amplifies inflammation within the TME.